A case of neck paraganglioma in a 49-year-old male: Case report and review of the literature

被引:0
作者
Alabdullah, Mohammad [1 ]
Alomar, Khaled [2 ]
Nseir, Mariana [1 ]
Alkhatab, Nour [1 ]
Chahine, Karim [1 ]
机构
[1] Damascus Hosp, Otolaryngol Dept, Damascus, Syria
[2] Damascus Univ, Univ Pediat Hosp, Damascus, Syria
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2023年 / 113卷
关键词
Case report; Paraganglioma; Head and neck; HNPGLS; PHEOCHROMOCYTOMA; DIAGNOSIS; HEAD; MANAGEMENT; GUIDELINE;
D O I
10.1016/j.ijscr.2023.109025
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction and significance: Paragangliomas are rare tumors that most commonly occur in the head and neck. They are typically slow-growing tumors that are often associated with genetic syndromes and mutations in the enzyme succinate dehydrogenase. Case presentation: We describe a case of a male patient who presented with ear pain and dysphagia. On physical examination, there was a left neck mass and swalling in the left oropharynx. The mass was excised through a cervical approach and it was found to be a vagal paraganglioma. Clinical discussion: A few cases of head and neck paragangliomas (HNPGLs) have been reported in the medical literature. These tumors often present as asymptomatic masses, but this case, the patient presented with ear pain and dysphagia the location of the mass in the parapharyngeal space presents a surgical challenge. HNPGLs should be considered in the differential diagnosis of any neck mass. Conclusion: Paragangliomas are generally considered to have a good prognosis when they are completely excised. They rarely metastasize to adjacent or distant tissues. Cervical approach is a valid option for complete excision of cervical paraganglioma.
引用
收藏
页数:6
相关论文
共 18 条
  • [1] The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines
    Agha, Riaz A.
    Franchi, Thomas
    Sohrabi, Catrin
    Mathew, Ginimol
    Kerwan, Ahmed
    Thoma, Achilles
    Beamish, Andrew J.
    Noureldin, Ashraf
    Rao, Ashwini
    Vasudevan, Baskaran
    Challacombe, Ben
    Perakath, Benjamin
    Kirshtein, Boris
    Ekser, Burcin
    Pramesh, C. S.
    Laskin, Daniel M.
    Machado-Aranda, David
    Miguel, Diana
    Pagano, Duilio
    Millham, Frederick H.
    Roy, Gaurav
    Kadioglu, Huseyin
    Nixon, Iain J.
    Mukhejree, Indraneil
    McCaul, James A.
    Ngu, James Chi-Yong
    Albrecht, Joerg
    Gomez Rivas, Juan
    Raveendran, Kandiah
    Derbyshire, Laura
    Ather, M. Hammad
    Thorat, Mangesh A.
    Valmasoni, Michele
    Bashashati, Mohammad
    Chalkoo, Mushtaq
    Teo, Nan Zun
    Raison, Nicholas
    Muensterer, Oliver J.
    Bradley, Patrick James
    Goel, Prabudh
    Pai, Prathamesh S.
    Afifi, Raafat Yahia
    Rosin, Richard David
    Coppola, Roberto
    Klappenbach, Roberto
    Wynn, Rolf
    De Wilde, Rudy Leon
    Surani, Salim
    Giordano, Salvatore
    Massarut, Samuele
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 84 : 226 - 230
  • [2] [Anonymous], 2022, FDA approves iobenguane I 131 for rare adrenal gland tumors
  • [3] Paragangliomas of the head and neck: diagnosis and treatment
    Boedeker, CC
    Ridder, GJ
    Schipper, J
    [J]. FAMILIAL CANCER, 2005, 4 (01) : 55 - 59
  • [4] Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA
    Bozkurt, Murat Fani
    Virgolini, Irene
    Balogova, Sona
    Beheshti, Mohsen
    Rubello, Domenico
    Decristoforo, Clemens
    Ambrosini, Valentina
    Kjaer, Andreas
    Delgado-Bolton, Roberto
    Kunikowska, Jolanta
    Oyen, Wim J. G.
    Chiti, Arturo
    Giammarile, Francesco
    Fanti, Stefano
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1588 - 1601
  • [5] Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review
    Daerr, Roland
    Kuhn, Matthias
    Bode, Christoph
    Bornstein, Stefan R.
    Pacak, Karel
    Lenders, Jacques W. M.
    Eisenhofer, Graeme
    [J]. ENDOCRINE, 2017, 56 (03) : 495 - 503
  • [6] Benign paragangliomas: Clinical presentation and treatment outcomes in 236 patients
    Erickson, D
    Kudva, YC
    Ebersold, MJ
    Thompson, GB
    Grant, CS
    Van Heerden, JA
    Young, WF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) : 5210 - 5216
  • [7] IDENTIFICATION, CLASSIFICATION, TREATMENT, AND PROGNOSIS OF LARYNGEAL PARAGANGLIOMA - REVIEW OF THE LITERATURE AND 8 NEW CASES
    FERLITO, A
    BARNES, L
    WENIG, BM
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1994, 103 (07) : 525 - 536
  • [8] Pheochromocytoma and Paraganglioma Genetics, Diagnosis, and Treatment
    Fishbein, Lauren
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 135 - +
  • [9] Malignant pheochromocytomas and paragangliomas: a diagnostic challenge
    Gimm, Oliver
    DeMicco, Catherine
    Perren, Aurel
    Giammarile, Francesco
    Walz, Martin K.
    Brunaud, Laurent
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (02) : 155 - 177
  • [10] Treatment of Malignant Pheochromocytoma/Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine Recommendation From a 22-Year Follow-up of 18 Patients
    Huang, Hui
    Abraham, Jame
    Hung, Elizabeth
    Averbuch, Steven
    Merino, Maria
    Steinberg, Seth M.
    Pacak, Karel
    Fojo, Tito
    [J]. CANCER, 2008, 113 (08) : 2020 - 2028